P52435 (RPB11_HUMAN) Homo sapiens (Human)

DNA-directed RNA polymerase II subunit RPB11-a UniProtKBInterProSTRINGInteractive Modelling

117 aa; Sequence (Fasta) 110 identical sequences

Available Structures

38 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Human core-PIC in the open state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;1-117
Assess
Human holo-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 10×ZN;1-117
Assess
Human core-PIC in the initial transcribing state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;1-117
Assess
Human core-PIC in the closed state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;1-117
Assess
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 17×ZN;SF4;1-117
Assess
Human core-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P19387; P19388; P20226; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
MG; 11×ZN;1-117
Assess
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;1-117
Assess
Human holo-PIC in the open state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;1-117
Assess
Human holo-PIC in the initial transcribing state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
MG; 11×ZN;1-117
Assess
Structure of the p53/RNA polymerase II assembly Heteromer
O15514; P04637; P19387; P19388; P24928; P30876; P36954; P52434; P53803; P61218; P62487; P62875;
MG;ZN;1-117
Assess
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;1-117
Assess
TFIID-based intermediate PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P21675; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;1-117
Assess
p53-bound TFIID-based core PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P20226; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;1-117
Assess
TFIID-based intermediate PIC on PUMA promoter Heteromer
A0A480TA59; A0A481BYI6; A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; O00268; P13984; P20226; P21675; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
10×ZN;MG;1-117
Assess
TFIID-based core PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;1-117
Assess
TFIID-based core PIC on PUMA promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; I3LCH3; I3LSI7; O00268; P13984; P20226; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;
ZN;MG;1-117
Assess
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
16×ZN;SF4;MG;1-117
Assess
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
MG; 16×ZN;SF4;1-116
Assess
Structure of an RNA polymerase II-DSIF transcription elongation complex Heteromer
A5PJW8; F2Z4H3; G3MZY8; O00267; P63272; Q1JQ91; Q2T9T3; Q32P73; Q32P78; Q32P79; Q32PE0; Q3T0Q3; Q3ZBC0; Q5E9B8;
ZN;MG;1-115
Assess
Structure of paused transcription complex Pol II-DSIF-NELF Heteromer
A0A287ADR4; F1RKE4; F1SKN8; I3LCB2; I3LCH3; I3LGP4; I3LJR4; I3LJZ9; I3LN51; I3LSI7; O00267; P60899; P63272; Q8IXH7; Q8WX92; Q9H3P2;
MG;ZN;1-115
Assess
Structure of activated transcription complex Pol II-DSIF-PAF-SPT6 Heteromer
A0A287ADR4; F1RKE4; F1SKN8; I3LCB2; I3LCH3; I3LGP4; I3LJR4; I3LJZ9; I3LN51; I3LSI7; O00267; P60899; P63272; Q6PD62; Q7KZ85; Q9GZS3;
ZN;MG;1-115
Assess
Structure of mammalian RNA polymerase II elongation complex inhibited by Alpha-amanitin Heteromer
A0A287ADR4; F1RKE4; F1SKN8; I3LCB2; I3LCH3; I3LGP4; I3LJR4; I3LJZ9; I3LN51; I3LSI7; P60899; P85421;
ZN;MG;1-115
Assess
Structure of complete, activated transcription complex Pol II-DSIF-PAF-SPT6 uncovers allosteric elo… Heteromer
A0A287ADR4; A0A4X1VYD0; F1RKE4; F1SKN8; I3LCB2; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; O00267; P60899; P63272; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q92541; Q9GZS3;
ZN;MG;1-115
Assess
Structure of a transcribing RNA polymerase II-U1 snRNP complex Heteromer
A0A0B8RVL1; A0A287ADR4; A0A4X1VYD0; F1RKE4; F1SKN8; I3LCB2; I3LCH3; I3LJZ9; I3LN51; I3LSI7; P08621; P09012; P11414; P60899; P62304; P62306; P62308; P62314; P62316; P62318; Q66K91;
ZN;MG;1-115
Assess
RNA polymerase II pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 15×ZN;ADP;MG;BEF;1-115
Assess
RNA polymerase II core pre-initiation complex with open promoter DNA Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P20226; P29083; P29084; P35269; P52655; P52657; P60899; Q00403;
10×ZN;MG;1-115
Assess
RNA polymerase II pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 17×ZN;MG;1-115
Assess
RNA polymerase II pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
SF4; 17×ZN;MG;1-115
Assess
RNA polymerase II core pre-initiation complex with closed promoter DNA in proximal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P20226; P29083; P29084; P35269; P52655; P52657; P60899; Q00403;
10×ZN;MG;1-115
Assess
Human Mediator with RNA Polymerase II Pre-initiation complex Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; A0JLT2; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; O43513; O60244; O75586; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7;
SF4; 18×ZN;MG;1-115
Assess
RNA polymerase II core pre-initiation complex with closed promoter DNA in distal position Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; P13984; P20226; P29083; P29084; P35269; P52655; P52657; P60899; Q00403;
10×ZN;MG;1-115
Assess
Cryo-EM structure of mammalian RNA polymerase II in complex with human RPAP2 Heteromer
A0A0B8RVL1; A0A4X1UK25; A0A4X1ULF2; F1SKN8; I3LCH3; I3LJR4; I3LN51; I3LSI7; P60899; Q8IXW5;
ZN;1-115
Assess
Structure of RPAP2-bound RNA polymerase II Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1UK25; A0A4X1ULF2; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; I3LCH3; P60899;
ZN;1-115
Assess
Structure of active transcription elongation complex Pol II-DSIF (SPT5-KOW5) Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; O00267; P60899;
MG;ZN;1-115
Assess
Structure of active transcription elongation complex Pol II-DSIF (SPT5-KOW5)-ELL2-EAF1 (composite s… Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; O00267; O00472; P11414; P60899; Q96JC9;
MG;ZN;1-115
Assess
Structure of active transcription elongation complex Pol II-DSIF-ELL2-EAF1(composite structure) Heteromer
A0A287ADR4; A0A4X1UK25; A0A4X1ULF2; A0A4X1VYD0; F1SKN8; I3LCH3; I3LGP4; I3LJZ9; I3LN51; I3LSI7; O00267; O00472; P11414; P60899; P63272; Q96JC9;
MG;ZN;1-115
Assess
Structure of transcribing mammalian RNA polymerase II Heteromer
A5PJW8; F2Z4H3; G3MZY8; Q1JQ91; Q2T9T3; Q32P73; Q32P78; Q32P79; Q32PE0; Q3T0Q3; Q3ZBC0; Q5E9B8;
ZN;MG;1-115
Assess
RNA Pol II(G) Heteromer
O15514; P0CAP2; P19387; P19388; P24928; P30876; P36954; P52434; P53803; P61218; P62487; P62875;
ZN;2-112
Assess

Alignments